MG
Mark T Giles
Director
Mark T GilesDirector
Mark T Giles insider trades: Diffusion Pharmaceuticals (DFFN) SEC Form 4 filings
Director, Diffusion Pharmaceuticals 11 Form 4 filings
11
Form 4 filings
last Jul 6, 2021
9
Grants and awards
filings
2
Other transactions
filings
2
Companies
Companies
Where Mark reports to the SEC
About Mark T Giles's insider trades
Mark T Giles is a director at Diffusion Pharmaceuticals (DFFN). Mark has not reported an open-market purchase or sale.
Their filings also include grants and awards (9 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DFFN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.